as on September 16, 2025 at 1:29 am IST
Day's Low
Day's High
0.03%
Downside
4.50%
Upside
52 Week's Low
52 Week's High
23.86%
Downside
23.43%
Upside
Check Dexcom, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$29.9B
EPS (TTM)
2.0503
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.27%
PE Ratio (TTM)
53.68
Industry PE ratio
16.65525641025641
P/B Ratio
53.6761
PEG Ratio
0.9712
EBITDA
923.3M
Revenue (TTM)
4.3B
Profit Margin
13.29%
Return On Equity TTM
22.83%
Track how Dexcom, Inc. P/E has moved over time to understand its valuation trends.
Dexcom, Inc. in the last 5 years
Lowest (44.87x)
December 31, 2024
Industry (16.66x)
September 15, 2025
Today (53.68x)
September 15, 2025
Highest (175.15x)
September 30, 2021
Today’s Price to Earnings Ratio: 53.68x
Compare market cap, revenue, PE, and other key metrics of Dexcom, Inc. with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
---|---|---|---|---|---|
BUY | $29.9B | -23.39% | 53.68 | 13.29% | |
BUY | $152.2B | 150.39% | 61.14 | 13.55% | |
BUY | $146.6B | 82.11% | 50.77 | 12.25% | |
BUY | $232.8B | 25.47% | 16.78 | 32.43% | |
BUY | $120.6B | -12.59% | 25.98 | 13.63% |
The Dexcom, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Dexcom, Inc. investment value today
Current value as on today
₹1,13,675
Returns
₹13,675
(+13.67%)
Returns from Dexcom, Inc. Stock
₹8,689 (+8.69%)
Dollar Returns*
₹4,985 (+4.99%)
Based on 30 analysts
86.67%
Buy
13.33%
Hold
0.00%
Sell
Based on 30 analysts, 86.67% of analysts recommend a 'BUY' rating for Dexcom, Inc.. Average target price of $102.08
Get share price movements and forecasts by analysts on Dexcom, Inc..
What analysts predicted
25.99%UPSIDE
Target Price
$102.08
Current Price
$75.55
Analyzed by
30 Analysts
Target
$102.08
Dexcom, Inc. target price $102.08, a slight upside of 25.99% compared to current price of $75.55. According to 30 analysts rating.
Investment in Dexcom, Inc. Shares on INDmoney has grown by 121.73% over the past 30 days, indicating increased transactional activity.
Time period: to
Change:121.73% versus previous 30 day period
Search interest for Dexcom, Inc. Stock has increased by 175% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:175% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Today's Timeline - 15 September
Mon, 12:46 PM
-Dexcom announces new features and data on glucose biosensing at EASD 2025, highlighting improved health outcomes and cost-effectiveness.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Profit Spike
Dexcom, Inc. has shown strong profit growth over the last two quarters. The company's net profit increased from $105.4 million to $179.8 million, representing an average quarterly growth of 41.4%. This positive trend indicates that the company's profitability has been consistently improving.
Revenue Rich
Dexcom, Inc. has shown positive revenue growth over the last two quarters. The revenue increased from $1.03 billion to $1.15 billion, marking an average growth of 10.5% each quarter.
Against Peers
In the last 3 years, Boston Scientific Corp. has given 146.3% return, outperforming this stock by 161.7%
Against Peers
In the last 1 year, Boston Scientific Corp. has given 23.0% return, outperforming this stock by 14.3%
Price Dip
In the last 7 days, DXCM stock has moved down by -2.8%
Organisation | Dexcom, Inc. |
Headquarters | 6340 Sequence Drive, San Diego, CA, United States, 92121 |
Industry | Health Technology |
CEO | Mr. Kevin Ronald Sayer |
E-voting on shares | Click here to vote |
Name | Title |
---|---|
Mr. Jacob Steven Leach | President & COO |
Ms. Sadie M. Stern | Executive VP & Chief Human Resources Officer |
Mr. Sean Christensen | Vice President of Finance and Investor Relations |
Mr. Matthew Dolan | Executive Vice President of Strategy & Corporate Development |
Ms. Leverne Marsh | Executive Vice President of Marketing |
Mr. Kevin Ronald Sayer | Executive Chairman & CEO |
Mr. Michael Jon Brown | Executive VP & Chief Legal Officer |
Mr. Girish Naganathan | Executive VP & CTO |
Mr. Donald M. Abbey | Executive Vice President of Global Business Services, IT, Quality & Regulatory Affairs |
Mr. Jereme M. Sylvain CPA | Executive VP, CFO & Chief Accounting Officer |
Dexcom, Inc. share price today is $75.55 as on at the close of the market. Dexcom, Inc. share today touched a day high of $78.95 and a low of $75.53.
Dexcom, Inc. share touched a 52 week high of $93.25 on and a 52 week low of $57.52 on . Dexcom, Inc. stock price today i.e. is closed at $75.55,which is 18.98% down from its 52 week high and 31.35% up from its 52 week low.
Dexcom, Inc. market capitalisation is $0.03T as on .
Indian investors can start investing in Dexcom, Inc. (DXCM) shares with as little as ₹88.141 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹881.41 in Dexcom, Inc. stock (as per the Rupee-Dollar exchange rate as on ).
Based on Dexcom, Inc. share’s latest price of $75.55 as on September 16, 2025 at 1:29 am IST, you will get 0.1324 shares of Dexcom, Inc.. Learn more about
fractional shares .
Dexcom, Inc. stock has given -23.39% share price returns and 20.01% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?